Publication | Closed Access

Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia

Hematological MalignancyChromatinHealth SciencesMedicineImatinib-induced NeutropeniaImmunologyHematologyCytogenetic ResponsesMyeloid NeoplasiaOncologyRadiation OncologyEpigeneticsChinese Patients